Effect of Sex Hormone-Binding Globulin on Polycystic Ovary Syndrome: Mechanisms, Manifestations, Genetics, and Treatment
Open accessThe DOI matches its Crossref record; 129 of the 129 references it cites were found in a registry or an index.
Abstract
Polycystic ovary syndrome (PCOS) is one of the most common endocrine diseases causing infertility in women of childbearing age. It is characterized by hyperandrogenemia (HA), chronic anovulation, and polycystic ovary morphology (PCOM). Most women with PCOS have metabolic abnormalities. Sex hormone-binding globulin (SHBG), a transport carrier that binds estrogen and androgens and regulates their biological activity, is usually used as an indicator of hyperandrogenism in women with PCOS. Low serum SHBG levels are considered a biomarker of metabolic abnormalities and are associated with insulin resistance (IR), HA, and abnormal glucose and lipid metabolism in PCOS patients. SHBG is also related to the long-term prognosis of PCOS, whereas SHBG gene polymorphism is associated with PCOS risk. In addition, the administration of metformin (MET), glucagon-like peptide-1 receptor agonists (GLP-1 RAs), thiazolidinediones (TZDs), compound oral contraceptives (COCs), as well as nutrient supplements such as inositol (MI), vitamin D, and synbiotics can regulate SHBG levels to ameliorate PCOS complications and improve prognosis. This review focuses on the interaction between SHBG and various PCOS complications as well as the regulation of SHBG by various drugs and nutrients and its therapeutic effects on PCOS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Moreover, increased plasma insulin levels also increase the amount of circulating free androgens by reducing the production of Sex Hormone-Binding Globulin (SHBG) in the liver [15].”
From Liraglutide and polycystic ovary syndrome: is it only a matter of body weight? (2023) · cites this paper as [15]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group (2004) · Human Reproduction · doi:10.1093/humrep/deh098 · Cited by 6,138
Mechanisms of Insulin Action and Insulin Resistance
Petersen, M. C., & Shulman, G. I. (2018) · Physiological Reviews · doi:10.1152/physrev.00063.2017 · Cited by 3,028
Teede, H. J., Misso, M. L., Costello, M. F., Dokras, A., Laven, J., Moran, L., Piltonen, T., Norman, R. J., International PCOS Network, Andersen, M., et al. (2018) · Human Reproduction · doi:10.1093/humrep/dey256 · Cited by 1,593
Adipose tissue dysfunction as determinant of obesity-associated metabolic complications
Longo, M., Zatterale, F., Naderi, J., Parrillo, L., Formisano, P., Raciti, G. A., Beguinot, F., & Miele, C. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20092358 · Cited by 1,575
The vitamin D deficiency pandemic: Approaches for diagnosis, treatment and prevention
Holick, M. F. (2017) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-017-9424-1 · Cited by 1,511
Lifestyle changes in women with polycystic ovary syndrome
Lim, S. S., Hutchison, S. K., Van Ryswyk, E., Norman, R. J., Teede, H. J., & Moran, L. J. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007506.pub4 · Cited by 725
Using human genetics to understand the disease impacts of testosterone in men and women
The Endometrial Cancer Association Consortium, Ruth, K. S., Day, F. R., Tyrrell, J., Thompson, D. J., Wood, A. R., Mahajan, A., Beaumont, R. N., Wittemans, L., Martin, S., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0751-5 · Cited by 720
PLYMATE, S. R., MATEJ, L. A., JONES, R. E., & FRIEDL, K. E. (1988) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-67-3-460 · Cited by 693
Transcriptional regulation of hepatic lipogenesis
Wang, Y., Viscarra, J., Kim, S.-J., & Sul, H. S. (2015) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm4074 · Cited by 646
Potential role and therapeutic interests of myo-inositol in metabolic diseases
Croze, M. L., & Soulage, C. O. (2013) · Biochimie · doi:10.1016/j.biochi.2013.05.011 · Cited by 578
The effect of obesity on polycystic ovary syndrome: a systematic review and meta‐analysis
Lim, S. S., Norman, R. J., Davies, M. J., & Moran, L. J. (2013) · Obesity Reviews · doi:10.1111/j.1467-789x.2012.01053.x · Cited by 539 · cited 1×
“Obesity aggravates the metabolic phenotype of PCOS, and the incidence of PCOS is higher in overweight and obese patients.(27) Low plasma SHBG levels have been shown to be related to obesity, especially abdominal obesity.”
BackgroundJonard, S. (2004) · Human Reproduction Update · doi:10.1093/humupd/dmh010 · Cited by 519
Role of Vitamin D in Insulin Secretion and Insulin Sensitivity for Glucose Homeostasis
Alvarez, J. A., & Ashraf, A. (2010) · International Journal of Endocrinology · doi:10.1155/2010/351385 · Cited by 481
Cassar, S., Misso, M. L., Hopkins, W. G., Shaw, C. S., Teede, H. J., & Stepto, N. K. (2016) · Human Reproduction · doi:10.1093/humrep/dew243 · Cited by 415 · cited 2×
“SHBG Levels and Hyperinsulinemia in Women with PCOS Approximately 75% of PCOS patients show IR, a prominent PCOS feature.(30) IR is a condition where the response of cells to a given environmental insulin concentration is lower than that of normal controls,(40) varying with tissue type.”
BackgroundA Reappraisal of Testosterone’s Binding in Circulation: Physiological and Clinical Implications
Goldman, A. L., Bhasin, S., Wu, F. C. W., Krishna, M., Matsumoto, A. M., & Jasuja, R. (2017) · Endocrine Reviews · doi:10.1210/er.2017-00025 · Cited by 414
Geographical Prevalence of Polycystic Ovary Syndrome as Determined by Region and Race/Ethnicity
Wolf, W. M., Wattick, R. A., Kinkade, O. N., & Olfert, M. D. (2018) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph15112589 · Cited by 413
Probiotics, prebiotics and amelioration of diseases
Tsai, Y.-L., Lin, T.-L., Chang, C.-J., Wu, T.-R., Lai, W.-F., Lu, C.-C., & Lai, H.-C. (2019) · Journal of Biomedical Science · doi:10.1186/s12929-018-0493-6 · Cited by 388
Plasma steroid-binding proteins: primary gatekeepers of steroid hormone action
Hammond, G. L. (2016) · Journal of Endocrinology · doi:10.1530/joe-16-0070 · Cited by 356
Novel insights in SHBG regulation and clinical implications
Simó, R., Sáez-López, C., Barbosa-Desongles, A., Hernández, C., & Selva, D. M. (2015) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2015.05.001 · Cited by 335
Diverse Roles for Sex Hormone-Binding Globulin in Reproduction
Hammond, G. L. (2011) · Biology of Reproduction · doi:10.1095/biolreprod.111.092593 · Cited by 317
Role of vitamin D in ovarian physiology and its implication in reproduction: a systematic review
Irani, M., & Merhi, Z. (2014) · Fertility and Sterility · doi:10.1016/j.fertnstert.2014.04.046 · Cited by 317
Lim, S. S., Kakoly, N. S., Tan, J. W. J., Fitzgerald, G., Bahri Khomami, M., Joham, A. E., Cooray, S. D., Misso, M. L., Norman, R. J., Harrison, C. L., et al. (2019) · Obesity Reviews · doi:10.1111/obr.12762 · Cited by 316 · cited 1×
“A meta-analysis revealed that obesity-related metabolic abnormalities in women with PCOS were associated with significantly reduced SHBG levels.(9) Since adolescents and children are increasingly becoming obese, obesity could affect the development of adolescent girls and increase PCOS risk.”
BackgroundVitamin D in the aetiology and management of polycystic ovary syndrome
Thomson, R. L., Spedding, S., & Buckley, J. D. (2012) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2012.04434.x · Cited by 310
Dapas, M., Lin, F. T. J., Nadkarni, G. N., Sisk, R., Legro, R. S., Urbanek, M., Hayes, M. G., & Dunaif, A. (2020) · PLOS Medicine · doi:10.1371/journal.pmed.1003132 · Cited by 297 · cited 2×
“The metabolic phenotype (non-reproductive group) with IR and low SHBG levels is a high-risk population for infertility.(6) Clinical studies in adolescent girls have shown that SHBG is a strong predictor of insulin sensitivity, and a decline in SHBG is indicative of IR development.”
BackgroundLifestyle changes in women with polycystic ovary syndrome
Moran, L. J., Hutchison, S. K., Norman, R. J., & Teede, H. J. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007506.pub3 · Cited by 292 · cited 1×
“PCOS management strategies include lifestyle changes, such as diet and physical activity, as a first-line treatment; however, these have been reported to have a negligible effect on reducing weight or treating PCOS-related symptoms.(12)”
BackgroundHoeger, K., Davidson, K., Kochman, L., Cherry, T., Kopin, L., & Guzick, D. S. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0461 · Cited by 256
Serum Vitamin D Levels and Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis
He, C., Lin, Z., Robb, S., & Ezeamama, A. (2015) · Nutrients · doi:10.3390/nu7064555 · Cited by 242
Monosaccharide-induced lipogenesis regulates the human hepatic sex hormone–binding globulin gene
Selva, D. M., Hogeveen, K. N., Innis, S. M., & Hammond, G. L. (2007) · Journal of Clinical Investigation · doi:10.1172/jci32249 · Cited by 232 · cited 8×
“In terms of reproduction, IR stimulates the production of ovarian androgens through insulin and aggravates HA with a reduction in SHBG.114 In terms of metabolism, IR is associated with impaired glucose tolerance, T2DM, and cardiovascular disease.”
BackgroundInfluentialQu, X., & Donnelly, R. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21218191 · Cited by 210 · cited 2×
“It can be speculated that increased liver adipogenesis may inhibit liver SHBG synthesis, leading to relative and absolute HA and ovarian dysfunction in PCOS.(11) On the contrary, low-carbohydrate diets, insulin sensitizers, and phytoestrogens can increase SHBG production by reducing liver fat production and ameliorati…”
BackgroundMyo-inositol effects in women with PCOS: a meta-analysis of randomized controlled trials
Unfer, V., Facchinetti, F., Orrù, B., Giordani, B., & Nestler, J. (2017) · Endocrine Connections · doi:10.1530/ec-17-0243 · Cited by 188
Effect of liraglutide on ectopic fat in polycystic ovary syndrome: Arandomized clinical trial
Frøssing, S., Nylander, M., Chabanova, E., Frystyk, J., Holst, J. J., Kistorp, C., Skouby, S. O., & Faber, J. (2018) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13053 · Cited by 178 · cited 5×
“The increase in SHBG levels in PCOS women after liraglutide treatment may be caused by a combination of weight loss, improvement in IR and HA.(89,90) Our previous meta-analysis confirmed that for overweight women with PCOS, MET combined with GLP-1 RAs appears to be superior to MET in ameliorating hyperandrogenemia, es…”
BackgroundInfluentialShorakae, S., Ranasinha, S., Abell, S., Lambert, G., Lambert, E., de Courten, B., & Teede, H. (2018) · Clinical Endocrinology · doi:10.1111/cen.13808 · Cited by 176 · cited 5×
“This increase is exaggerated in adolescent women prone to PCOS, further enlarging their ovaries and increasing androgen production by theca cells, leading to ovarian HA.50 Thus, decreased SHBG levels in the liver in NAFLD patients may trigger a cascade of excessive androgen production in adolescents, leading to PCOS d…”
BackgroundInfluentialSex hormone-binding globulin gene expression in the liver: Drugs and the metabolic syndrome
PUGEAT, M. M., Nader, N., Hogeveen, K. N., Raverot, G., Déchaud, H., & Grenot, C. (2009) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2009.09.020 · Cited by 176
Treatment strategies for women with polycystic ovary syndrome
Jin, P., & Xie, Y. (2018) · Gynecological Endocrinology · doi:10.1080/09513590.2017.1395841 · Cited by 175
Sex hormone-binding globulin and polycystic ovary syndrome
Zhu, J.-L., Chen, Z., Feng, W.-J., Long, S.-L., & Mo, Z.-C. (2019) · Clinica Chimica Acta · doi:10.1016/j.cca.2019.09.010 · Cited by 169
Combined oral contraceptives in the treatment of polycystic ovary syndrome
Vrbíková, J., & Cibula, D. (2005) · Human Reproduction Update · doi:10.1093/humupd/dmi005 · Cited by 163
Childhood Obesity and Its Impact on the Development of Adolescent PCOS
Anderson, A., Solorzano, C. M. B., & McCartney, C. R. (2014) · Seminars in Reproductive Medicine · doi:10.1055/s-0034-1371092 · Cited by 162
Lass, N., Kleber, M., Winkel, K., Wunsch, R., & Reinehr, T. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-1609 · Cited by 160
Effects of Inositol(s) in Women with PCOS: A Systematic Review of Randomized Controlled Trials
Unfer, V., Nestler, J. E., Kamenov, Z. A., Prapas, N., & Facchinetti, F. (2016) · International Journal of Endocrinology · doi:10.1155/2016/1849162 · Cited by 151
Selva, D. M., & Hammond, G. L. (2009) · Journal of Molecular Endocrinology · doi:10.1677/jme-09-0025 · Cited by 150
Costello, M., Misso, M. L., Balen, A. H., Boyle, J., Devoto, L., Garad, R. M., Hart, R. J., Johnson, L., Jordan, C., Legro, R. S., et al. (2018) · Human Reproduction Open · doi:10.1093/hropen/hoy021 · Cited by 147
Bioactive molecules of probiotic bacteria and their mechanism of action: A review
Indira, M., Venkateswarulu, T. C., Abraham Peele, K., Nazneen Bobby, M., & Krupanidhi, S. (2019) · 3 Biotech · doi:10.1007/s13205-019-1841-2 · Cited by 147
Fang, F., Ni, K., Cai, Y., Shang, J., Zhang, X., & Xiong, C. (2016) · Complementary Therapies in Clinical Practice · doi:10.1016/j.ctcp.2016.11.008 · Cited by 146
The reproductive phenotype in polycystic ovary syndrome
Chang, R. J. (2007) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0637 · Cited by 145
Nylander, M., Frøssing, S., Clausen, H. V., Kistorp, C., Faber, J., & Skouby, S. O. (2017) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2017.03.023 · Cited by 139
Cousin, P., Michel‐Calemard, L., Lejeune, H., Raverot, G., Yessaad, N., Emptoz-Bonneton, A., Morel, Y., & PUGEAT, M. M. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021553 · Cited by 134
A review of therapeutic options for managing the metabolic aspects of polycystic ovary syndrome
Abdalla, M. A., Deshmukh, H., Atkin, S. L., & Sathyapalan, T. (2020) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018820938305 · Cited by 132
Łagowska, K., Bajerska, J., & Jamka, M. (2018) · Nutrients · doi:10.3390/nu10111637 · Cited by 132
Potential Role of Tumor Necrosis Factor-α in Downregulating Sex Hormone–Binding Globulin
Simó, R., Barbosa-Desongles, A., Lecube, A., Hernandez, C., & Selva, D. M. (2012) · Diabetes · doi:10.2337/db11-0727 · Cited by 127
Down-Regulation of Hepatic HNF4α Gene Expression during Hyperinsulinemia via SREBPs
Xie, X., Liao, H., Dang, H., Pang, W., Guan, Y., Wang, X., Shyy, J. Y.-J., Zhu, Y., & Sladek, F. M. (2009) · Molecular Endocrinology · doi:10.1210/me.2007-0531 · Cited by 127
The role of vitamin D in metabolic disturbances in polycystic ovary syndrome: a systematic review
Krul-Poel, Y. H. M., Snackey, C., Louwers, Y., Lips, P., Lambalk, C. B., Laven, J. S. E., & Simsek, S. (2013) · European Journal of Endocrinology · doi:10.1530/eje-13-0617 · Cited by 126
Handelsman, D. J., Sikaris, K., & Ly, L. P. (2016) · Annals of Clinical Biochemistry: International Journal of Laboratory Medicine · doi:10.1177/0004563215610589 · Cited by 122 · cited 8×
“In terms of reproduction, IR stimulates the production of ovarian androgens through insulin and aggravates HA with a reduction in SHBG.114 In terms of metabolism, IR is associated with impaired glucose tolerance, T2DM, and cardiovascular disease.”
BackgroundInfluentialThe effects of old, new and emerging medicines on metabolic aberrations in PCOS
Bargiota, A., & Diamanti-Kandarakis, E. (2012) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018812437355 · Cited by 119
Shamasbi, S. G., Ghanbari‐Homayi, S., & Mirghafourvand, M. (2019) · European Journal of Nutrition · doi:10.1007/s00394-019-02033-1 · Cited by 118
Jamilian, M., Foroozanfard, F., Rahmani, E., Talebi, M., Bahmani, F., & Asemi, Z. (2017) · Nutrients · doi:10.3390/nu9121280 · Cited by 115
Cirillo, F., Catellani, C., Lazzeroni, P., Sartori, C., Nicoli, A., Amarri, S., Sala, G. B. L., & Street, M. E. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00879 · Cited by 112
Guan, Y., Wang, D., Bu, H., Zhao, T., & Wang, H. (2020) · International Journal of Endocrinology · doi:10.1155/2020/5150684 · Cited by 106
Evolving utility of sex hormone-binding globulin measurements in clinical medicine
Hammond, G. L., Wu, T.-S., & Simard, M. (2012) · Current Opinion in Endocrinology, Diabetes & Obesity · doi:10.1097/med.0b013e328353732f · Cited by 104
Haqq, L., McFarlane, J., Dieberg, G., & Smart, N. (2014) · Endocrine Connections · doi:10.1530/ec-14-0010 · Cited by 101
Outeiriño-Iglesias, V., Romaní-Pérez, M., González-Matías, L. C., Vigo, E., & Mallo, F. (2015) · Endocrinology · doi:10.1210/en.2014-1978 · Cited by 99 · cited 1×
“Acute intracerebral injection of GLP-1 promotes an immediate increase in LH levels before ovulation and significantly increases estrogen and progesterone levels as well as the number of mature follicles.(87) GLP1RA is also expressed in the ovaries, and it significantly suppresses progesterone levels without affecting…”
BackgroundFacchinetti, F., Orrù, B., Grandi, G., & Unfer, V. (2019) · Gynecological Endocrinology · doi:10.1080/09513590.2018.1540578 · Cited by 94 · cited 2×
“In addition, the superior tolerance to MI makes it suitable for the recovery of androgen and metabolic characteristics in women with PCOS.(105)”
BackgroundResultAdiponectin Upregulates SHBG Production: Molecular Mechanisms and Potential Implications
Simó, R., Sáez‐López, C., Lecube, A., Hernández, C., Fort, J. M., & Selva, D. M. (2014) · Endocrinology · doi:10.1210/en.2014-1072 · Cited by 92
Schoppee, P. D., Garmey, J. C., & Veldhuis, J. D. (2002) · Biology of Reproduction · doi:10.1095/biolreprod66.1.190 · Cited by 92
Oróstica, L., Astorga, I., Plaza-Parrochia, F., Vera, C., Pérez‐García, V. M., Carvajal, R., Gabler, F., Romero, C., & Vega, M. (2016) · International Journal of Obesity · doi:10.1038/ijo.2016.154 · Cited by 92
Genetic Variants Associated with Hyperandrogenemia in PCOS Pathophysiology
Dadachanji, R., Shaikh, N., & Mukherjee, S. (2018) · Genetics Research International · doi:10.1155/2018/7624932 · Cited by 90 · cited 1×
“Hyperinsulinemia caused by obesity can also directly stimulate the ovaries and adrenal glands of women with PCOS to produce excessive androgens.(32)”
BackgroundSimó, R., Barbosa-Desongles, A., Hernández, C., & Selva, D. M. (2012) · Molecular Endocrinology · doi:10.1210/me.2012-1152 · Cited by 90
Feng, C., Jin, Z., Chi, X., Zhang, B., Wang, X., Sun, L., Fan, J., Sun, Q., & Zhang, X. (2018) · Gynecological Endocrinology · doi:10.1080/09513590.2017.1411474 · Cited by 90
New biomarkers for diagnosis and management of polycystic ovary syndrome
Karakas, S. E. (2017) · Clinica Chimica Acta · doi:10.1016/j.cca.2017.06.009 · Cited by 89
Yamazaki, H., Kushiyama, A., Sakoda, H., Fujishiro, M., Yamamotoya, T., Nakatsu, Y., Kikuchi, T., Kaneko, S., Tanaka, H., & Asano, T. (2018) · Mediators of Inflammation · doi:10.1155/2018/3062319 · Cited by 86 · cited 1×
“SHBG inhibits inflammation and lipid accumulation in macrophages and adipocytes, which may be a potential mechanism underlying the protective effects of SHBG in reducing the incidence of metabolic syndrome and its complications.(59)”
BackgroundNasri, K., Jamilian, M., Rahmani, E., Bahmani, F., Tajabadi-Ebrahimi, M., & Asemi, Z. (2018) · BMC Endocrine Disorders · doi:10.1186/s12902-018-0248-0 · Cited by 86
Xu, Y., Wu, Y., & Huang, Q. (2017) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-017-4480-z · Cited by 86
Metabolic effect of obesity on polycystic ovary syndrome in adolescents: a meta-analysis
Li, L., Feng, Q., Ye, M., He, Y., Yao, A., & Shi, K. (2017) · Journal of Obstetrics and Gynaecology · doi:10.1080/01443615.2017.1318840 · Cited by 85
Insulin Sensitizers for Improving the Endocrine and Metabolic Profile in Overweight Women With PCOS
Xing, C., Li, C., & He, B. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa337 · Cited by 84
Self-citationSex Hormone-Binding Globulin: Gene Organization and Structure/Function Analyses
Hammond, G. L., & Bocchinfuso, W. P. (2008) · Hormone Research · doi:10.1159/000184787 · Cited by 84
Gandhi, M., & Martin, S. (2015) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/j.ogc.2015.01.012 · Cited by 77
Molecular Mechanism of TNFα-Induced Down-Regulation of SHBG Expression
Simó, R., Barbosa-Desongles, A., Sáez‐López, C., Lecube, A., Hernández, C., & Selva, D. M. (2012) · Molecular Endocrinology · doi:10.1210/me.2011-1321 · Cited by 75
Su, P., Henriksson, A., & Mitchell, H. (2007) · Journal of Applied Microbiology · doi:10.1111/j.1365-2672.2007.03469.x · Cited by 75
Loughrill, E., Wray, D. S., Christides, T., & Zand, N. (2016) · Maternal and Child Nutrition · doi:10.1111/mcn.12368 · Cited by 74
Effects of vitamin D supplementation in women with polycystic ovary syndrome: a review
Menichini, D., & Facchinetti, F. (2020) · Gynecological Endocrinology · doi:10.1080/09513590.2019.1625881 · Cited by 73
Lim, A. J. R., Huang, Z., Chua, S. E., Kramer, M. S., & Yong, E.-L. (2016) · PLOS ONE · doi:10.1371/journal.pone.0167048 · Cited by 72
Sex Hormone-Binding Globulin Reduction in Metabolic Disorders May Play a Role in NAFLD Development
(2017) · EndocrinologyJN · doi:10.1210/en.2016-1668 · Cited by 71
Yilmaz, M., İsaoğlu, Ü., Delibaş, İ. B., & Kadanalı, S. (2011) · Journal of obstetrics and gynaecology research · doi:10.1111/j.1447-0756.2010.01478.x · Cited by 71
Nokoff, N., Thurston, J., Hilkin, A., Pyle, L., Zeitler, P. S., Nadeau, K. J., Santoro, N., & Kelsey, M. M. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-02747 · Cited by 71
Çınar, N., & Gürlek, A. (2013) · Endocrine Connections · doi:10.1530/ec-13-0061 · Cited by 70
Polymorphisms in theSHBGGene Influence Serum SHBG Levels in Women with Polycystic Ovary Syndrome
Wickham, E. P., Ewens, K. G., Legro, R. S., Dunaif, A. E., Nestler, J. E., & Strauss, J. F. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-1842 · Cited by 67
Ferk, P., Teran, N., & Gersak, K. (2007) · Human Reproduction · doi:10.1093/humrep/del457 · Cited by 67
Peroxisome-Proliferator Receptor γ Represses Hepatic Sex Hormone-Binding Globulin Expression
Selva, D. M., & Hammond, G. L. (2009) · Endocrinology · doi:10.1210/en.2008-1289 · Cited by 66
Heppner, K. M., Baquero, A. F., Bennett, C. M., Lindsley, S. R., Kirigiti, M. A., Bennett, B. J., Bosch, M. A., Mercer, A. J., Rønnekleiv, O. K., True, C. A., et al. (2017) · eNeuro · doi:10.1523/eneuro.0198-16.2016 · Cited by 64
The LH/FSH ratio has little use in diagnosing polycystic ovarian syndrome
Cho, L. W., Jayagopal, V., Kilpatrick, E. S., Holding, S., & Atkin, S. L. (2006) · Annals of Clinical Biochemistry: International Journal of Laboratory Medicine · doi:10.1258/000456306776865188 · Cited by 63
Karamali, M., Eghbalpour, S., Rajabi, S., Jamilian, M., Bahmani, F., Ebrahimi, M. T., Keneshlou, F., Mirhashemi, S. M., Chamani, M., Gelougerdi, S. H., et al. (2018) · PubMed · Cited by 62
Abdalla, M. A., Deshmukh, H., Atkin, S., & Sathyapalan, T. (2021) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018821989238 · Cited by 60
Azadi‐Yazdi, M., Nadjarzadeh, A., Khosravi‐Boroujeni, H., & Salehi‐Abargouei, A. (2017) · Hormone and Metabolic Research · doi:10.1055/s-0043-103573 · Cited by 59
Tawfeek, M., Alfadhli, E. M., Alayoubi, A. M., El-Beshbishy, H. A., & Habib, F. (2017) · BMC Women s Health · doi:10.1186/s12905-017-0373-3 · Cited by 58
Effect of Metformin on Microvascular Endothelial Function in Polycystic Ovary Syndrome
Heidari, B., Lerman, A., Lalia, A. Z., Lerman, L. O., & Chang, A. Y. (2019) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2019.06.015 · Cited by 57
Angellotti, E., D’Alessio, D. A., Dawson-Hughes, B. F., Nelson, J., Cohen, R. M., Gastaldelli, A., & Pittas, A. G. (2018) · Journal of the Endocrine Society · doi:10.1210/js.2018-00015 · Cited by 55
Martinez-Garcia, M. A., Gambineri, A., Alpanes, M., Sanchon, R., Pasquali, R., & Escobar-Morreale, H. F. (2012) · Human Reproduction · doi:10.1093/humrep/des335 · Cited by 50
Fulghesu, A. M., Romualdi, D., Di Florio, C., Sanna, S., Tagliaferri, V., Gambineri, A., Tomassoni, F., Minerba, L., Pasquali, R., & Lanzone, A. (2012) · Human Reproduction · doi:10.1093/humrep/des262 · Cited by 48 · cited 1×
“The observed poor compliance has prompted clinicians worldwide to find new ways to treat PCOS.(79) Table 1 Characteristics of the Included RCTs of Intervention on Changes of Serum SHBG”
Background(2013) · PubMed · doi:10.3275/9023 · Cited by 48
Wu, L., Wang, Y.-X., Zhan, Y., Liu, A.-H., Wang, Y., Shen, H., Wang, Y.-F., Wang, L., Tao, Z., & Wang, Y. (2021) · Peptides · doi:10.1016/j.peptides.2021.170624 · Cited by 44
Nishiyama, Y., Hasegawa, T., Fujita, S., Iwata, N., Nagao, S., Hosoya, T., Inagaki, K., Wada, J., & Otsuka, F. (2018) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2017.11.004 · Cited by 43
Comparison clinical and metabolic effects of metformin and pioglitazone in polycystic ovary syndrome
Shahebrahimi, K., Jalilian, N., Bazgir, N., & Rezaei, M. (2016) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/2230-8210.192925 · Cited by 43
Guo, S., Tal, R., Jiang, H., Yuan, T., & Liu, Y. (2020) · International Journal of Endocrinology · doi:10.1155/2020/7850816 · Cited by 42
Xita, N., Georgiou, I., Lazaros, L., Psofaki, V., Kolios, G., & Tsatsoulis, A. (2008) · European Journal of Endocrinology · doi:10.1530/eje-07-0905 · Cited by 42
Incretin-based therapies in prediabetes: Current evidence and future perspectives
Papaetis, G. S. (2014) · World Journal of Diabetes · doi:10.4239/wjd.v5.i6.817 · Cited by 41
Amiri, M., Kabir, A., Nahidi, F., Shekofteh, M., & Ramezani Tehrani, F. (2018) · The European Journal of Contraception & Reproductive Health Care · doi:10.1080/13625187.2018.1435779 · Cited by 40 · cited 1×
“All COCs studies showed a similar increase in SHBG levels and decreases in the Ferriman–Gallwey (FG) score, T, FT, A4, and DHEAS levels; however, products containing cyproterone acetate (CPA) may be the most effective treatment for hirsute PCOS patients.(100) In addition, a clinical study by Morgante et al showed that…”
BackgroundGholinezhad, M., Gholsorkhtabaramiri, M., Esmaeilzadeh, S., & Ghanbarpour, A. (2018) · PubMed Central · doi:10.22088/cjim.9.3.260 · Cited by 40
Tzotzas, T., Karras, S., & Katsiki, N. (2017) · Current Vascular Pharmacology · doi:10.2174/1570161114666161221115324 · Cited by 39
Saez-Lopez, C., Villena, J. A., Simó, R., & Selva, D. M. (2020) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2020.108480 · Cited by 38 · cited 3×
“The increase in SHBG levels in PCOS women after liraglutide treatment may be caused by a combination of weight loss, improvement in IR and HA.89,90 Our previous meta-analysis confirmed that for overweight women with PCOS, MET combined with GLP-1 RAs appears to be superior to MET in ameliorating hyperandrogenemia, espe…”
BackgroundSáez-López, C., Salcedo-Allende, M. T., Hernandez, C., Simó-Servat, O., Simó, R., & Selva, D. M. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-00740 · Cited by 38
Ong, M., Cheng, J., Jin, X., Lao, W., Johnson, M. S., Tan, Y., & Qu, X. (2018) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2018.09.006 · Cited by 36
Identifying genes associated with the development of human polycystic ovary syndrome
Saddick, S. (2020) · Saudi Journal of Biological Sciences · doi:10.1016/j.sjbs.2020.01.012 · Cited by 35
Abu-Hijleh, T. M., Gammoh, E., Al-Busaidi, A. S., Malalla, Z. H., Madan, S., Mahmood, N., & Almawi, W. Y. (2016) · Annals of Nutrition and Metabolism · doi:10.1159/000441570 · Cited by 31
Liu, C., Huang, S., Cheng, K., Hsieh, T., Huang, C., Wang, C., Yeh, H., Tsai, C.-C., Bao, B., Wu, W., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-03078-0 · Cited by 31
Sáez‐López, C., Briansó‐Llort, L., Torres‐Torronteras, J., Simó, R., Hammond, G. L., & Selva, D. M. (2017) · Scientific Reports · doi:10.1038/s41598-017-12509-x · Cited by 28
Bennett, W. L., Aschmann, H. E., Puhan, M. A., Robbins, C. W., Bayliss, E. A., Wilson, R. F., Mularski, R. A., Chan, W., Leff, B. A., Sheehan, O. C., et al. (2019) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2019.03.014 · Cited by 24
Metabolic and androgen profile in underweight women with polycystic ovary syndrome
Anastasiou, O. E., Canbay, A. E., Führer, D., & Tan, S. (2017) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-017-4422-9 · Cited by 24
Yabe, D., Seino, Y., & Seino, Y. (2017) · Journal of Diabetes Investigation · doi:10.1111/jdi.12718 · Cited by 23
Huang, M., Liu, J., Lin, X., Goto, A., Song, Y., Tinker, L. F., Chan, K. H. K., & Liu, S. (2017) · Journal of Diabetes · doi:10.1111/1753-0407.12550 · Cited by 22
Lin, X., Wu, R., Du, J., Liao, Y., Du, Y. Z., Ye, Y., Wang, Y., Zhang, X. B., Wu, C., & Chen, A. (2015) · Clinical and Experimental Obstetrics & Gynecology · doi:10.12891/ceog1779.2015 · Cited by 22
Xing, C., Lv, B., Zhao, H., Wang, D., Li, X., & He, B. (2021) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2021.105992 · Cited by 21
Self-citationEndogenous SHBG levels correlate with that of glucose transporters in insulin resistance model cells
Feng, C., Jin, Z., Sun, L., Wang, X., Chi, X., Zhang, X., & Lian, S. (2019) · Molecular Biology Reports · doi:10.1007/s11033-019-04946-w · Cited by 20
Hacıhanefioğlu, B., Aybey, B., Hakan Özön, Y., Berkil, H., & Karşıdağ, K. (2013) · Gynecological Endocrinology · doi:10.3109/09513590.2012.743006 · Cited by 16
Morgante, G., Cappelli, V., Troìa, L., & Leo, V. D. (2020) · The European Journal of Contraception & Reproductive Health Care · doi:10.1080/13625187.2020.1736546 · Cited by 16
Un rôle pour PPARγ dans la reproduction ?
Froment, P., Gizard, F., Staels, B., Dupont, J., & Monget, P. (2005) · médecine/sciences · doi:10.1051/medsci/2005215507 · Cited by 16
Yin, Y., Zhang, Y., Zhang, H., Jiang, D., & Guo, G. (2018) · PubMed · doi:10.13703/j.0255-2930.2018.01.006 · Cited by 14
Ferjan, S., Jensterle, M., Oblak, T., Žitnik, I. P., Marc, J., Goričar, K., Dolžan, V., & Janež, A. (2019) · Journal of International Medical Research · doi:10.1177/0300060519865351 · Cited by 12
Does sex hormone-binding globulin cause insulin resistance during pubertal growth?
Le, S., Xu, L., Schumann, M., Wu, N., Törmäkangas, T., Alén, M., Cheng, S., & Wiklund, P. (2019) · Endocrine Connections · doi:10.1530/ec-19-0044 · Cited by 12
Association between the (TAAAA)nSHBGpolymorphism and PCOS: a systematic review and meta-analysis
Fan, W., Li, S., Chen, Q., & Huang, Z. (2013) · Gynecological Endocrinology · doi:10.3109/09513590.2013.797394 · Cited by 11
Zhang, J., Huang, J., He, X., Li, N., Yu, M., Li, B., Shao, X., & Wang, N. (2021) · Gynecological Endocrinology · doi:10.1080/09513590.2021.2011198 · Cited by 3
Self-citation
Research works printed but not linked: 2
- Moran, 2011, Cochrane Database Syst Rev, 2, CD007506
- Karamali, 2018, Arch Iran Med, 21, 1
Cited by
Obesity and Dyslipidemia: A Review of Current Evidence
Vekić, J., Stefanović, A., & Zeljković, A. (2023) · Current Obesity Reports · doi:10.1007/s13679-023-00518-z · Cited by 194
Mu, L., Ye, Z., Hu, J., Zhang, Y., Chen, K., Sun, H., Li, R., Mao, W., Long, X., Zhang, C., et al. (2023) · EBioMedicine · doi:10.1016/j.ebiom.2023.104492 · Cited by 78
Approach to Investigation of Hyperandrogenism in a Postmenopausal Woman
Hirschberg, A. L. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac673 · Cited by 73
Zarezadeh, M., Musazadeh, V., Faghfouri, A. H., Sarmadi, B., Jamilian, P., Jamilian, P., Tutunchi, H., & Dehghan, P. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106397 · Cited by 49
Chiang, Y., Lin, I., Huang, K., Chen, H.-Y., Ali, M. K., Huang, Y., & Hsia, S. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115327 · Cited by 48
Metadata
- Authors
- Xing, C., Zhang, J., Zhao, H., & He, B.
- Affiliations
- Sheng Jing Hospital (CN)
- Corresponding author
- He, Bing
- Venue
- International Journal of Women's Health
- Publisher
- Informa UK Limited
- Published
- 2022-02
- Volume
- Volume 14
- Pages
- 91-105
- ISSN
- 1179-1411 (ISSN-L)
- PMC
- PMC8818772
- OpenAlex
- W4210722375
- Cited by
- 118
- References
- 126
- Citations by year
- 2026: 33 · 2025: 31 · 2024: 23 · 2023: 26 · 2022: 5
- FWCI
- 3.42
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Women s Health (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Dove Medical Press (Taylor and Francis Group) (submittedVersion, cc-by-nc)
- Funders
- National Natural Science Foundation of China (81570765)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic and Kidney Cyst Diseases
- Health Sciences › Medicine › Reproductive Medicine › Reproductive Biology and Fertility
- Keywords
- polycystic ovary syndrome, sex hormone-binding globulin, hyperandrogenemia, insulin resistance, metabolic abnormalities, metformin, GLP-1 receptor agonists, thiazolidinediones, oral contraceptives, myo-inositol, vitamin D, synbiotics, PCOS treatment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.